We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.17B
AUM Growth
-$6.4M
(-0.29%)
Cap. Flow
+$112M
Cap. Flow % of AUM
Cap. Flow %
5.15%
Top 10 Holdings %
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,387
Reduced
1,049
Closed
222
Avg Time Held
Equity + Options
3.1
years
Top 10 Avg Time Held
Equity + Options
2.1
years
Top 20 Avg Time Held
Equity + Options
2
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$42.9M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$36.8M |
| 3 |
Corcept Therapeutics
CORT
|
+$28.1M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$20.3M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$24.4M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$21.7M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$17.5M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.55% |
| 2 | Technology | 12.45% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 8.7% |
| 5 | Consumer Discretionary | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Atlanta Braves Holdings Series A
BATRA
$3.47B
| $0 | ﹤0.01% |
11
| – | – |
2020 Q2
9 quarters
|
|
3077
Barings BDC
BBDC
$884M
| $0 | ﹤0.01% |
18
-198
| -92% | -$1.91K |
2021 Q1
6 quarters
|
|
3078
BridgeBio Pharma
BBIO
$13B
| – | – |
-34
| Closed | – | – |
|
3079
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.45B
| $0 | ﹤0.01% |
+12
| New | +$295 |
2022 Q3
0 quarters
|
|
3080
BioCryst Pharmaceuticals
BCRX
$1.99B
| $0 | ﹤0.01% |
+10
| New | +$129 |
2022 Q3
0 quarters
|
|
3081
Bicycle Therapeutics
BCYC
$242M
| $0 | ﹤0.01% |
5
| – | – |
2021 Q4
3 quarters
|
|
3082
Roundhill Sports Betting & iGaming ETF
BETZ
$41.1M
| $0 | ﹤0.01% |
10
| – | – |
2021 Q1
6 quarters
|
|
3083
Saul Centers
BFS
$729M
| $0 | ﹤0.01% |
2
-2
| -50% | -$92 |
2021 Q3
4 quarters
|
|
3084
BGC Group
BGC
$5.4B
| – | – |
-539
| Closed | -$2K | – |
|
3085
Bioceres Crop Solutions
BIOX
$17.6M
| $0 | ﹤0.01% |
+8
| New | +$98 |
2022 Q3
0 quarters
|
|
3086
Black Hills Corp
BKH
$5.84B
| $0 | ﹤0.01% |
4
-1
| -20% | -$75 |
2021 Q2
5 quarters
|
|
3087
Ballard Power Systems
BLDP
$551M
| – | – |
-8
| Closed | – | – |
|
3088
Blink Charging
BLNK
$61.4M
| $0 | ﹤0.01% |
10
| – | – |
2022 Q1
2 quarters
|
|
3089
DELISTED
bluebird bio
BLUE
| $0 | ﹤0.01% |
+3
| New | +$339 |
2022 Q3
0 quarters
|
|
3090
Bionano Genomics
BNGO
$14.7M
| – | – |
0
| – | – |
2022 Q1
2 quarters
|
|
3091
Boston Omaha
BOC
$378M
| $0 | ﹤0.01% |
12
| – | – |
2022 Q2
1 quarter
|
|
3092
Boot Barn
BOOT
$3.69B
| – | – |
-66
| Closed | -$5K | – |
|
3093
DELISTED
Blueprint Medicines
BPMC
| $0 | ﹤0.01% |
+6
| New | +$385 |
2022 Q3
0 quarters
|
|
3094
BellRing Brands
BRBR
$1.1B
| $0 | ﹤0.01% |
4
-12
| -75% | -$288 |
2021 Q4
3 quarters
|
|
3095
AGF US Market Neutral Anti-Beta Fund
BTAL
$333M
| $0 | ﹤0.01% |
23
| – | – |
2020 Q1
10 quarters
|
|
3096
Bit Digital
BTBT
$346M
| $0 | ﹤0.01% |
1
| – | – |
2021 Q3
4 quarters
|
|
3097
BrightView Holdings
BV
$976M
| $0 | ﹤0.01% |
34
+16
| +89% | +$171 |
2022 Q2
1 quarter
|
|
3098
Bioventus
BVS
$908M
| – | – |
-33
| Closed | – | – |
|
3099
Babcock & Wilcox
BW
$688M
| $0 | ﹤0.01% |
12
-113
| -90% | -$840 |
2022 Q2
1 quarter
|
|
3100
BlueLinx
BXC
$579M
| – | – |
-2
| Closed | – | – |
|
Similar funds
Parallel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,387 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.
- Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
- Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
- Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
- Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
- Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
- Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
- Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.
Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.